郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Biaryl sulfonamide motifs up- or down-regulate ion channel activity by activating voltage sensors.

期刊：The Journal of general physiology发表年份：2018作者：Sara I Liin; Per-Eric Lund; Johan E Larsson; Johan Brask; Björn Wallner; Fredrik Elinder
阅读更多 →

药效评价Binding conformation and determinants of a single-chain peptide antagonist at the relaxin-3 receptor RXFP3.

期刊：The Journal of biological chemistry发表年份：2018作者：Linda M Haugaard-Kedström; Han Siean Lee; Maryon V Jones; Angela Song; Vishaal Rathod; Mohammed Akhter Hossain; Ross A D Bathgate; K Johan Rosengren
阅读更多 →

药效评价The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies.

期刊：Toxicologic pathology发表年份：2018作者：Maja M Janas; Carole E Harbison; Victoria K Perry; Brenda Carito; Jessica E Sutherland; Akshay K Vaishnaw; Natalie D Keirstead; Garvin Warner
阅读更多 →

药效评价Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target.

期刊：Biochemical pharmacology发表年份：2018作者：Linlin Ma; Yanni K Y Chin; Zoltan Dekan; Volker Herzig; Chun Yuen Chow; Jacqueline Heighway; Sau Wing Lam; Gilles J Guillemin; Paul F Alewood; Glenn F King
阅读更多 →